Public acceptance of RSV vaccine grows in the U.S. as hesitancy plateaus--poll

Public acceptance of RSV vaccine grows as hesitancy plateaus A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, according to a new Annenberg Public Policy Center (APPC) ... Annenberg Public Policy Center of the University of Pennsylvania Medical Xpress

...

Over half of U.S. adults (52%) think the vaccine given to pregnant individuals to protect their infants from RSV (respiratory syncytial virus) is effective, up from 42% in October 2023, soon after the Centers for Disease Control and Prevention (CDC) recommended the vaccine. And 61% say the RSV vaccine for adults age 60 and older is effective, up from 54% in October 2023.

...